Gonococcal infection of other male genital organs
ICD-10 A54.23 is a billable code used to indicate a diagnosis of gonococcal infection of other male genital organs.
Gonococcal infection of other male genital organs refers to the infection caused by the bacterium Neisseria gonorrhoeae, which primarily affects the urethra but can also involve other male genital structures such as the epididymis, prostate, and seminal vesicles. This sexually transmitted infection (STI) is characterized by symptoms such as urethral discharge, dysuria, and in some cases, pain or swelling in the affected areas. If left untreated, gonococcal infections can lead to serious complications, including infertility, epididymitis, and disseminated gonococcal infection (DGI), which can affect joints and skin. Diagnosis is typically made through laboratory testing, including nucleic acid amplification tests (NAATs) or culture methods. Treatment usually involves antibiotics, with dual therapy recommended to combat potential antibiotic resistance. Contact tracing is crucial to prevent further transmission, as asymptomatic individuals can unknowingly spread the infection. Regular screening and education about safe sexual practices are essential components of managing gonococcal infections.
Detailed notes on the patient's symptoms, examination findings, and any diagnostic tests performed.
Patients presenting with dysuria, urethral discharge, or scrotal pain.
Urologists should ensure that all relevant symptoms and examination findings are documented to support the diagnosis.
Comprehensive patient history, including sexual history and previous STI infections.
Patients with recurrent STIs or those presenting with systemic symptoms.
Infectious disease specialists should document the rationale for testing and treatment choices.
Used for diagnosing gonococcal infections in symptomatic patients.
Document the reason for testing and any relevant patient history.
Urologists and infectious disease specialists should ensure comprehensive documentation to support the necessity of the test.
Common symptoms include dysuria, urethral discharge, and pain in the genital area. Some individuals may be asymptomatic.
Diagnosis is typically made through laboratory tests, including nucleic acid amplification tests (NAATs) or cultures.
The CDC recommends dual therapy with ceftriaxone and azithromycin to effectively treat gonococcal infections.
Contact tracing helps identify and treat sexual partners to prevent further transmission of the infection.
